Suppr超能文献

从健康受试者以及克罗恩病患者粪便中分离并鉴定粘性高分子量微生物碳水化合物组分及其对治疗方法的影响。

Isolation and characterization of the viscous, high-molecular-mass microbial carbohydrate fraction from faeces of healthy subjects and patients with Crohn's disease and the consequences for a therapeutic approach.

作者信息

Ruseler-van Embden J G, Van Lieshout L M, Binnema D J, Hazenberg M P

机构信息

Department of Immunology, Erasmus University, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands.

出版信息

Clin Sci (Lond). 1998 Oct;95(4):425-33.

PMID:9748418
Abstract
  1. An earlier study by our group revealed that the viscosity of faeces from patients with Crohn's disease is significantly lower than that of healthy subjects. This is due to low concentrations of a high-molecular-mass carbohydrate, probably of bacterial origin. The cause of this phenomenon might be the impaired barrier function of the gut mucosa. Low viscosity may allow close contact of intestinal contents (bacterial products and toxins) with the intestinal wall. This could play a role in the maintenance of the disease.2. The first aim of this study was to investigate the high-molecular-mass carbohydrate fraction, responsible for viscosity, in detail. We also tried (in a pilot study) to raise the intestinal viscosity of patients with Crohn's disease with the undegradable food additive hydroxypropylcellulose (E463), in an attempt to alleviate clinical symptoms.3. The high-molecular-mass fraction (>300 kDa) responsible for faecal viscosity was sensitive to lysozyme and contained high levels of muramic acid. It was concluded that this material consisted mainly of peptidoglycan polysaccharides and was consequently of bacterial origin. The muramic acid in material from patients with Crohn's disease was 7.5 (1.5-13.9)%, which was less than in healthy subjects [11.4 (8.5-24.1)%; P=0.0004]. Furthermore, viscosity in material from patients with Crohn's disease was found to be half [14.9 (1.0-33.6) cP] of that found in healthy subjects [35.0 (2.7-90.7) cP; P=0.004].4.A daily dose of 1 g of hydroxypropylcellulose caused an increase in faecal viscosity in patients with Crohn's disease (from 1.4 to 2.3 cP) and in healthy subjects (from 4.9 to 7.5 cP). Faecal consistency improved in patients with Crohn's disease (from watery and loose to formed) and the defecation frequency decreased from 3-4 to about 2 times a day. No changes in defecation patterns were found in healthy subjects.5. These data indicate that the high-molecular-mass fraction that is responsible for faecal viscosity is peptidoglycan. Furthermore, a daily dose of a hydroxypropylcellulose solution to increase the viscosity of the intestinal contents of patients with Crohn's disease might be beneficial. This approach merits further study.
摘要
  1. 我们团队早期的一项研究表明,克罗恩病患者粪便的黏度显著低于健康受试者。这是由于一种高分子量碳水化合物的浓度较低,其可能源自细菌。这种现象的原因可能是肠黏膜屏障功能受损。低黏度可能使肠内容物(细菌产物和毒素)与肠壁紧密接触。这可能在疾病的维持中起作用。

  2. 本研究的首要目的是详细调查导致粪便黏度的高分子量碳水化合物部分。我们还(在一项初步研究中)尝试用不可降解的食品添加剂羟丙基纤维素(E463)提高克罗恩病患者的肠道黏度,以试图缓解临床症状。

  3. 导致粪便黏度的高分子量部分(>300 kDa)对溶菌酶敏感且含有高水平的胞壁酸。得出的结论是,该物质主要由肽聚糖多糖组成,因此源自细菌。克罗恩病患者粪便中胞壁酸含量为7.5(1.5 - 13.9)%,低于健康受试者[11.4(8.5 - 24.1)%;P = 0.0004]。此外,发现克罗恩病患者粪便的黏度是健康受试者的一半[14.9(1.0 - 33.6)厘泊],健康受试者的黏度为[35.0(2.7 - 90.7)厘泊;P = 0.004]。

  4. 每日服用1克羟丙基纤维素可使克罗恩病患者的粪便黏度增加(从1.4增至2.3厘泊),也可使健康受试者的粪便黏度增加(从4.9增至7.5厘泊)。克罗恩病患者的粪便稠度得到改善(从水样便和稀便变为成形便),排便频率从每天3 - 4次降至约每天2次。健康受试者的排便模式未发现变化。

  5. 这些数据表明,导致粪便黏度的高分子量部分是肽聚糖。此外,每日服用羟丙基纤维素溶液以增加克罗恩病患者肠内容物的黏度可能有益。这种方法值得进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验